September 24, 2018
Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.
May 10, 2018
We announce $2.5 million in new funding, which reflects the comprehensive nature of our strategy to prevent and treat Alzheimer’s disease.
March 14, 2018
ADDF-supported research was at the forefront of the Summit and the National Plan to Address Alzheimer's.
October 30, 2017
Wednesday marked the beginning of National Alzheimer's Disease Awareness Month and the 10th Clinical Trials on Alzheimer's Disease conference, which featured a record amount of research we supported.
September 13, 2017
Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.
September 5, 2017
At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.
June 29, 2017
Dr. Lauren Friedman details the three topics that dominated discussions at this year's BIO International Convention.
September 21, 2016
On World Alzheimer’s Day, we celebrate the progress made toward finding effective treatments and look toward the future.
January 15, 2015
In 2014, we had a transformative year, advancing drugs for Alzheimer's, supporting the best science, and ensuring people have information to protect their brain health.
September 24, 2014
Presenters at our recent conference shared exciting progress on new Alzheimer's drug targets and biomarkers.
July 28, 2014
Our neuroscientists share highlights from their favorite sessions at the 2014 Alzheimer’s Association International Conference (AAIC) in Copenhagen, Denmark.
May 8, 2014
Aging is the single greatest risk factor for Alzheimer’s disease. The challenge is translating this knowledge into a cure for the disease.
August 20, 2013
The ADDF presents its annual fall conference on Alzheimer's drug discovery on September 9-10, 2013 in Jersey City, New Jersey.
© Copyright 2024. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).